Cytek biosciences earnings call
WebTARSONS PRODUCTS LIMITED : News, Nachrichten und Informationen Aktie TARSONS PRODUCTS LIMITED INE144Z01023 Bombay Stock Exchange WebResearch tools you need to invest in the public markets. We make listening to earnings calls easy.
Cytek biosciences earnings call
Did you know?
WebCTKB Earnings Date Latest Press Release Published Aug 10, 2024 Cytek Biosciences Reports Second Quarter 2024 Financial Results Earnings Per Share Estimated … WebFeb 28, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks...
WebFeb 28, 2024 · 2024 Outlook. Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 ... WebView Cytek Biosciences (www.cytekbio.com) location in California, United States , revenue, industry and description. ... Q4 and Full Year 2024 Earnings Call Transcript Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul Goodson – Investor ...
Web1 day ago · Call Transcripts. Guidance. Indici. Valute/Forex. Materie Prime. ... Transcript : Bio-Rad Laboratories, Inc., Q4 2024 Earnings Call, Feb 16, 2024: CI. ... trimestre e l'.. CI. 08/02: Element Biosciences e Bio-Rad collaborano per offrire un flusso di lavoro di sequenziam.. CI. 07/02: Cytek Biosciences, Bio-Rad collaborano alla produzione di ... WebAug 10, 2024 · Q2 2024 Cytek Biosciences Inc Earnings Call Sep 21, 2024 (Thomson StreetEvents) -- Edited Transcript of Cytek Biosciences Inc earnings conference call …
WebMar 31, 2024 · Cytek Biosciences - CTKB News Today $9.19 +0.28 (+3.14%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $8.95 $9.39 50-Day Range $8.44 $13.47 52-Week Range $7.38 $16.05 Volume 1.11 million shs Average Volume 737,749 shs Market Capitalization $1.24 billion P/E Ratio 459.73 Dividend Yield N/A Price Target …
WebMar 1, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul … darkhistories.comWebAug 10, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.16 million for the quarter ended June 2024, missing the Zacks Consensus... bishop elementary school sunnyvaleWebApr 5, 2024 · CYTEK BIOSCIENCES, INC. company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: CTKB Nasdaq. ... Acquisition of Flow Cytometry & Imaging Business From DiaSorin By Cytek Biosciences, Inc Call: 12/01/22 08:30am : Piper Sandler Healthcare Conference - Fireside chat: 11/09/22 06:50pm : dark historical romance booksWebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? bishop eliasWebIn the wake of Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest US$70m market cap drop, institutional owners may be forced to take severe actions. Simply Wall St. Sep-07-22 01:27AM. RGAIA Investment: Cytek Biosciences (CTKB) is Profitable Today & Will be Even More So in the Future. Insider Monkey +5.29%. dark histories youtubeWeb34 rows · Feb 23, 2024 · Recent Highlights. Total revenue was $38.9 million for the fourth quarter and $128.0 million for the ... dark histories podcastWebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024. dark histories podcast host